[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100621204":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":23,"centralContacts":27,"locations":33,"responsibleParty":49,"collaborators":23,"id":53,"slug":54,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":23,"eligibilityCriteria":59,"healthyVolunteers":55,"sex":60,"minAge":61,"maxAge":62,"enrollmentInfo":63,"targetDuration":23,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":23,"overallStatus":36,"whyStopped":23,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},{"fullName":5,"class":6},"National Cancer Institute, Egypt","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"CTFB Group","EXPERIMENTAL","Patients will receive an ipsilateral ultrasound-guided costotransverse foramen block with injection of 20 ml bupivacaine 0.25%.",[13],"Other: Costotransverse foramen block",{"label":15,"type":10,"description":16,"interventionNames":17},"TPVB Group","Patients will receive an ipsilateral ultrasound-guided thoracic paravertebral plane block with injection of 20 ml bupivacaine 0.25%.",[18],"Other: Thoracic paravertebral plane block",[20,24],{"type":6,"name":21,"description":11,"armGroupLabels":22,"otherNames":23},"Costotransverse foramen block",[9],null,{"type":6,"name":25,"description":16,"armGroupLabels":26,"otherNames":23},"Thoracic paravertebral plane block",[15],[28],{"name":29,"role":30,"phone":31,"phoneExt":23,"email":32},"Mai M Elrawas, MD","CONTACT","00201222177242","mai.elrawas@nci.cu.edu.eg",[34],{"facility":35,"status":36,"city":37,"state":23,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"Cairo University","RECRUITING","Cairo","12613","Egypt","EG",{"type":42,"coordinates":43},"Point",[44,45],31.24967,30.06263,{"lat":45,"lon":44},[48],{"name":29,"role":30,"phone":31,"phoneExt":23,"email":32},{"type":50,"investigatorFullName":51,"investigatorTitle":52,"investigatorAffiliation":5,"oldNameTitle":23,"oldOrganization":23},"PRINCIPAL_INVESTIGATOR","Mai Mohamed El Rawas","Assistant professor of Anaesthesia, Intensive Care and Pain Management, National Cancer Institute, Cairo University Cairo University, Cairo, Egypt.","100621204","costotransverse-foramen-block-versus-thoracic-paravertebral-block-in-thoracotomy-for-lung-cancer-100621204",false,"NCT07367581","Costotransverse Foramen Block Versus Thoracic Paravertebral Block in Thoracotomy for Lung Cancer","Costotransverse Foramen Block Versus Thoracic Paravertebral Block in Thoracotomy for Lung Cancer: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Age \\> 18 years and ≤ 65 years old.\n* American Society of Anesthesiologists (ASA) physical status II-III.\n* Body mass index 18-35 kg\u002Fm2.\n* Patients scheduled for thoracotomies for lung cancer.\n\nExclusion Criteria:\n\n* Patient refusal.\n* History of sensitivity to local anesthetics.\n* History of psychological disorders.\n* Contraindication to regional anesthesia, e.g., local sepsis, pre-existing peripheral neuropathies, and coagulopathy.\n* Severe respiratory, cardiac, hepatic, or renal disease.\n* Morbid obesity.\n* Uncooperative patients.\n* Patients on chronic pain therapy.","ALL","18 Years","65 Years",{"count":64,"type":65},70,"ESTIMATED","INTERVENTIONAL",[68],"NA","This study aims to compare the costotransverse foramen block (CTFB) with thoracic paravertebral block (TPVB) in patients undergoing thoracotomy for lung cancer.",[71,72,73,74],"Costotransverse Foramen Block","Thoracic Paravertebral Block","Thoracotomy","Lung Cancer","2026-01-24",{"date":77,"type":78},"2026-01-27","ACTUAL",{"date":75,"type":78},{"date":81,"type":65},"2026-06-01",{"name":5,"class":6},1]